Effectiveness of a Three-Week Inpatient Pulmonary Rehabilitation Program for Patients After COVID-19: A Prospective Observational Study

Overview

Journal Int J Environ Res Public Health

Publisher MDPI

Specialties Environmental Health
Public Health

Date 2021 Sep 10

PMID 34501596

Citations 33

Authors

Markus C Hayden

Matthias Limbach

Michael Schuler

Steffen Merkl

Gabriele Schwarzl

Katalin Jakab

Dennis Nowak

Konrad Schultz

Affiliations

Soon will be listed here.

Abstract

For COVID-19 patients who remain symptomatic after the acute phase, pulmonary rehabilitation (PR) is recommended. However, only a few studies have investigated the effectiveness of PR, especially considering the duration between the acute phase of COVID-19 and the onset of rehabilitation, as well as the initial severity. This prospective observational study evaluated the efficacy of PR in patients after COVID-19. A total of 120 still-symptomatic patients referred for PR after overcoming acute COVID-19 were asked to participate, of whom 108 (mean age 55.6 ± 10.1 years, 45.4% female) consented. The patients were assigned to three groups according to the time of referral and initial disease severity (severe acute; severe after interval; mild after interval). The primary outcome was dyspnea. Secondary outcomes included other respiratory disease symptoms, physical capacity, lung function, fatigue, quality of life (QoL), depression, and anxiety. Furthermore, patients rated the overall effectiveness of PR and their subjective change in health status. At the end of PR, we detected improvements with large effect sizes in exertional dyspnea, physical capacity, QoL, fatigue, and depression in the overall group. Other parameters changed with small to medium effect sizes. PR was effective after acute COVID-19 in all three groups analyzed.

Citing Articles

Identifying Factors That Might Affect Outcomes of Exercise-Based Therapies in Long-COVID.

Kruger A, Haiduk B, Grau M Diseases. 2024; 12(11).

PMID: 39589967 PMC: 11593325. DOI: 10.3390/diseases12110293.

Changes in lung function and dyspnea perception in Colombian Covid-19 patients after a 12-week pulmonary rehabilitation program.

Paez-Mora C, Zona D, Angarita-Sierra T, Rojas-Paredes M, Cano-Trejos D PLoS One. 2024; 19(11):e0300826.

PMID: 39546545 PMC: 11567541. DOI: 10.1371/journal.pone.0300826.

Impact of post-COVID symptoms on activity and participation of women and men.

Rosenstein J, Lemhofer C, Loudovici-Krug D, Sturm C, Bokel A Sci Rep. 2024; 14(1):24379.

PMID: 39420197 PMC: 11486897. DOI: 10.1038/s41598-024-74568-1.

The Impact of COVID-19 on Functional Capacity and Pulmonary Outcomes in the Hail Region: A Cross-Sectional Study.

Althomali O, Hussain Shaik D, Kanwal R, Amin J, Acar T, Abdelmoniem Ibrahim A J Clin Med. 2024; 13(18).

PMID: 39337058 PMC: 11433494. DOI: 10.3390/jcm13185571.

Pulmonary rehabilitation in follow-up and inpatient rehabilitation for Long COVID: twelve months of follow-up.

Rutsch M, Buhr-Schinner H, Gross T, Schuller P, Deck R Eur J Phys Rehabil Med. 2024; 60(4):716-728.

PMID: 38903009 PMC: 11403629. DOI: 10.23736/S1973-9087.24.08207-8.

References

Spruit M, Holland A, Singh S, Tonia T, Wilson K, Troosters T . COVID-19: interim guidance on rehabilitation in the hospital and post-hospital phase from a European Respiratory Society- and American Thoracic Society-coordinated international task force. Eur Respir J. 2020; 56(6. PMC: 7427118. DOI: 10.1183/13993003.02197-2020. View

Carfi A, Bernabei R, Landi F . Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020; 324(6):603-605. PMC: 7349096. DOI: 10.1001/jama.2020.12603. View

Gloeckl R, Leitl D, Jarosch I, Schneeberger T, Nell C, Stenzel N . Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study. ERJ Open Res. 2021; 7(2). PMC: 7957293. DOI: 10.1183/23120541.00108-2021. View

Criee C, Sorichter S, Smith H, Kardos P, Merget R, Heise D . Body plethysmography--its principles and clinical use. Respir Med. 2011; 105(7):959-71. DOI: 10.1016/j.rmed.2011.02.006. View

Carod-Artal F . [Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved]. Rev Neurol. 2021; 72(11):384-396. DOI: 10.33588/rn.7211.2021230. View

Nehme M, Braillard O, Alcoba G, Perone S, Courvoisier D, Chappuis F . COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings. Ann Intern Med. 2020; 174(5):723-725. PMC: 7741180. DOI: 10.7326/M20-5926. View

Kroenke K, Spitzer R, Williams J . The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16(9):606-13. PMC: 1495268. DOI: 10.1046/j.1525-1497.2001.016009606.x. View

Holland A, Spruit M, Troosters T, Puhan M, Pepin V, Saey D . An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014; 44(6):1428-46. DOI: 10.1183/09031936.00150314. View

Blanco J, Cobos-Ceballos M, Navarro F, Sanjoaquin I, Arnaiz De Las Revillas F, Bernal E . Pulmonary long-term consequences of COVID-19 infections after hospital discharge. Clin Microbiol Infect. 2021; 27(6):892-896. PMC: 7920814. DOI: 10.1016/j.cmi.2021.02.019. View

10.

Spitzer R, Kroenke K, Williams J, Lowe B . A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006; 166(10):1092-7. DOI: 10.1001/archinte.166.10.1092. View

11.

Mendoza T, Wang X, Cleeland C, Morrissey M, Johnson B, Wendt J . The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer. 1999; 85(5):1186-96. DOI: 10.1002/(sici)1097-0142(19990301)85:5<1186::aid-cncr24>3.0.co;2-n. View

12.

Curci C, Negrini F, Ferrillo M, Bergonzi R, Bonacci E, Camozzi D . Functional outcome after inpatient rehabilitation in postintensive care unit COVID-19 patients: findings and clinical implications from a real-practice retrospective study. Eur J Phys Rehabil Med. 2021; 57(3):443-450. DOI: 10.23736/S1973-9087.20.06660-5. View

13.

Fayol A, Livrozet M, Boutouyrie P, Khettab H, Betton M, Tea V . Cardiac performance in patients hospitalized with COVID-19: a 6 month follow-up study. ESC Heart Fail. 2021; 8(3):2232-2239. PMC: 8120370. DOI: 10.1002/ehf2.13315. View

14.

Halpin S, McIvor C, Whyatt G, Adams A, Harvey O, McLean L . Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2020; 93(2):1013-1022. DOI: 10.1002/jmv.26368. View

15.

Hermann M, Pekacka-Egli A, Witassek F, Baumgaertner R, Schoendorf S, Spielmanns M . Feasibility and Efficacy of Cardiopulmonary Rehabilitation After COVID-19. Am J Phys Med Rehabil. 2020; 99(10):865-869. PMC: 7406212. DOI: 10.1097/PHM.0000000000001549. View

16.

Greulich T, Koczulla A, Nell C, Kehr K, Vogelmeier C, Stojanovic D . Effect of a Three-Week Inpatient Rehabilitation Program on 544 Consecutive Patients with Very Severe COPD: A Retrospective Analysis. Respiration. 2015; 90(4):287-92. DOI: 10.1159/000436979. View

17.

Glockl R, Buhr-Schinner H, Koczulla A, Schipmann R, Schultz K, Spielmanns M . [Recommendations from the German Respiratory Society for Pulmonary Rehabilitation in Patients with COVID-19]. Pneumologie. 2020; 74(8):496-504. PMC: 7516360. DOI: 10.1055/a-1193-9315. View

18.

de Sire A, Andrenelli E, Negrini F, Patrini M, Lazzarini S, Ceravolo M . Rehabilitation and COVID-19: a rapid living systematic review by Cochrane Rehabilitation Field updated as of December 31st, 2020 and synthesis of the scientific literature of 2020. Eur J Phys Rehabil Med. 2021; 57(2):181-188. DOI: 10.23736/S1973-9087.21.06870-2. View

19.

Cortes-Telles A, Lopez-Romero S, Figueroa-Hurtado E, Pou-Aguilar Y, Wong A, Milne K . Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea. Respir Physiol Neurobiol. 2021; 288:103644. PMC: 7910142. DOI: 10.1016/j.resp.2021.103644. View

20.

Kamper S, Maher C, Mackay G . Global rating of change scales: a review of strengths and weaknesses and considerations for design. J Man Manip Ther. 2010; 17(3):163-70. PMC: 2762832. DOI: 10.1179/jmt.2009.17.3.163. View